Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
D. E. Shaw & Co., L.P. XPOF Xponential Fitness, Inc. 13G/A 7.5% 2y
T. Rowe Price Investment Management, Inc. CLW Clearwater Paper Corp 13G/A 8.1% 2y
Deep Track Capital, LP NKTR Nektar Therapeutics 13G/A 9.65% 2y
AMERIPRISE FINANCIAL INC USAP Universal Stainless & Alloy 13G/A 4.11% 2y
Strategic Value Investors LP SBFG Sb Financial Group, Inc. 13G/A 5.2% 2y
AWM Investment Company, Inc. AIOT Powerfleet, Inc. 13G 9.2% 2y
Radcliffe Capital Management, L.P. TRCA Twin Ridge Capital Acquisition Corp. 13G/A 0% 2y
BIGLARI CAPITAL CORP. LOCO El Pollo Loco Holdings, Inc. 13G/A 12.5% 2y
Deep Track Capital, LP AUTL Autolus Therapeutics plc 13G/A 6.82% 2y
Lytton, Laurence W. RVSN Rail Vision Ltd. 13G/A 9.3% 2y
Huazhi Hu EH EHang Holdings Ltd 13G/A 31.5% 2y
AMERIPRISE FINANCIAL INC GDRX GoodRx Holdings, Inc. 13G 7.58% 2y
NOMURA HOLDINGS INC HGAS Global Gas Corp 13G/A 0% 2y
TYBOURNE CAPITAL MANAGEMENT (HK) LTD FBRX Forte Biosciences, Inc. 13G 9.99% 2y
Shaolin Capital Management LLC CLRCF ClimateRock 13G/A 5.76% 2y
Nantahala Capital Management, LLC BVS Bioventus Inc. 13G/A 9.5% 2y
Ionic Ventures, LLC ZVSA ZyVersa Therapeutics, Inc. 13G/A 4% 2y
Churchill Sponsor IV LLC LCID Lucid Group, Inc. 13G/A 1.39% 2y
ARMISTICE CAPITAL, LLC GTBP GT Biopharma, Inc. 13G/A 4.99% 2y
Royal Bank of Canada ARMK Aramark 13G/A 2.2% 2y
METEORA CAPITAL, LLC XAGE Longevity Health Holdings, Inc. 13G 7.55% 2y
PRICE T ROWE ASSOCIATES INC /MD/ WY Weyerhaeuser Co 13G/A 6.6% 2y
EVENTIDE ASSET MANAGEMENT, LLC PRAX Praxis Precision Medicines, Inc. 13G/A 0% 2y
GREENLIGHT CAPITAL INC TLIS Talis Biomedical Corporation Common Stock 13G/A 8.2% 2y
CVI Investments, Inc. GNPX Genprex, Inc. 13G/A 4.9% 2y
METEORA CAPITAL, LLC MCAA Mountain & Co. I Acquisition Corp. Class A Ordinary Shares 13G 8.7% 2y
FIR TREE CAPITAL MANAGEMENT LP ESYN EnerSyn Global Inc. 13G 7.71% 2y
TANG CAPITAL MANAGEMENT, LLC ALGS Aligos Therapeutics, Inc. 13G/A 3% 2y
Granahan Investment Management, LLC LOVE Lovesac Co 13G/A 9.21% 2y
PRICE T ROWE ASSOCIATES INC /MD/ TEAM Atlassian Corp 13G/A 6.6% 2y
ORBIMED ADVISORS LLC SIBN SI-BONE, Inc. 13G/A 5.3% 2y
Venrock Healthcare Capital Partners III, L.P. KALV KalVista Pharmaceuticals, Inc. 13G/A 14% 2y
Venrock Healthcare Capital Partners III, L.P. CELC Celcuity Inc. 13G/A 9.99% 2y
Point72 Asset Management, L.P. EOSE Eos Energy Enterprises, Inc. 13G/A 2% 2y
COHEN & STEERS, INC. SUI Sun Communities Inc 13G/A 11.14% 2y
Whitefort Capital Management, LP CEE Central & Eastern Europe Fund, Inc. 13G/A 4.8% 2y
ARMISTICE CAPITAL, LLC VVOS Vivos Therapeutics, Inc. 13G 9.99% 2y
METEORA CAPITAL, LLC RMGC RMG Acquisition Corp. III Class A Ordinary Shares 13G 5.47% 2y
Insight Acquisition Sponsor LLC AMOD Alpha Modus Holdings, Inc. 13G/A 76% 2y
NB Alternatives Advisers LLC OPRT Oportun Financial Corp 13G 9.9% 2y
ARMISTICE CAPITAL, LLC ABEO Abeona Therapeutics Inc. 13G/A 4.99% 2y
ALLIANCEBERNSTEIN L.P. MGYR Magyar Bancorp, Inc. 13G/A 9.9% 2y
Walleye Capital LLC RMGC RMG Acquisition Corp. III Class A Ordinary Shares 13G 40.51% 2y
Radcliffe Capital Management, L.P. BNAI Brand Engagement Network Inc. 13G/A 0% 2y
Westchester Capital Management, LLC CVII Churchill Capital Corp VII Class A Common Stock 13G 7.07% 2y
Hood River Capital Management LLC HCI HCI Group, Inc. 13G 7.43% 2y
Lion Point Capital, LP DRRX Durect Corp 13G/A 0% 2y
Sandia Investment Management LP SEDA SDCL EDGE Acquisition Corporation 13G/A 10.62% 2y
Schonfeld Strategic Advisors LLC GCMG GCM Grosvenor Inc. 13G/A 0.1% 2y
TTWFGP LLC WLK Westlake Corp 13G/A 72.9% 2y